Stock GLAXO GLAXOSMITHKLINE PHARMACEUTICALS LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Company GlaxoSmithKline Pharmaceuticals Limited NSE India S.E.

Equities

GLAXO

INE159A01016

Pharmaceuticals

Market Closed - NSE India S.E.
Other stock markets
 09:03:22 2024-04-25 am EDT 		5-day change 1st Jan Change
2,066 INR -0.56% Intraday chart for GlaxoSmithKline Pharmaceuticals Limited +9.40% +8.82%
Apr. 25 GlaxoSmithKline sues Pfizer and BioNTech over Covid-19 vaccine technology RE
Mar. 22 GlaxoSmithKline Pharmaceuticals Limited Receives Orders from Government Authorities CI

Business Summary

GlaxoSmithKline Pharmaceuticals Limited is an India-based global healthcare company. The Company is engaged in the business of manufacturing, distributing and trading in pharmaceuticals. It has three product areas: vaccines, specialty and general medicines. Its general medicines business has a portfolio of medicines in anti-infectives, pain, dermatology and vitamins. Its general medicines brands include Augmentin, Calpol, Ceftum, Eltroxin, CCM, Neosporin, Betnovate, T-bact and Physiogel. Its T-bact brand products are used in specific types of bacterial skin infections. The Company's vaccine brands include Shingrix, Infanrix Hexa, Synflorix, Boostrix, Havrix, Menveo, Fluarix Tetra and Varilrix. Its specialty medicines business is focused on developing medicines for respiratory diseases and human immunodeficiency virus. The Company is also building its presence in other therapeutic areas, such as immunology and oncology. Its specialty medicines brands include Nucala and Trelegy Ellipta.

Number of employees: 3,680

Sales per Business

INR in Million2022Weight2023Weight Delta
Pharmaceuticals
100.0 %
32,780 100.0 % 32,517 100.0 % -0.80%

Sales per region

INR in Million2022Weight2023Weight Delta
India
98.0 %
31,961 97.5 % 31,877 98.0 % -0.26%
Foreign
2.0 %
819 2.5 % 640 2.0 % -21.85%

Managers

Managers TitleAgeSince
Bhushan Akshikar CEO
 Chief Executive Officer 54 22-11-30
Juby Chandy DFI
 Director of Finance/CFO - 22-03-31
Simrat Sohal CMP
 Compliance Officer - -
Priyanka Bhatia CTO
 Chief Tech/Sci/R&D Officer - -
Ajay A. Nadkarni ADM
 Chief Administrative Officer - 01-11-30
Ransom D'Souza IRO
 Public Communications Contact - 17-04-16
Chinmay Sharma HRO
 Human Resources Officer - 20-11-30
Sukanya Choudhary LAW
 General Counsel - 17-01-17
Amit Gaurishnkar Pandey LAW
 General Counsel - -

Members of the board

Members of the board TitleAgeSince
Renu Sud Karnad CHM
 Chairman 70 19-03-31
Manu Anand BRD
 Director/Board Member 64 22-05-15
Pradeep Vasudeo Bhide BRD
 Director/Board Member 74 15-03-29
Anami Narayan Prema Roy BRD
 Director/Board Member 73 11-11-03
Damodarannair Sundaram BRD
 Director/Board Member 71 15-03-29
Sunita Maheshwari BRD
 Director/Board Member 58 20-05-17
Subesh Williams BRD
 Director/Board Member 62 17-04-06
Juby Chandy DFI
 Director of Finance/CFO - 22-03-31

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 169,410,000 41,365,025 ( 24.42 %) 0 24.42 %

Shareholders

NameEquities%Valuation
GSK PLC
75.00 %
127,054,524 75.00 % 2 960 M ₹
Life Insurance Corporation of India (Investment Portfolio)
3.356 %
5,684,773 3.356 % 132 M ₹
General Insurance Corp. of India (Invt Port)
1.455 %
2,464,482 1.455 % 57 M ₹
Scottish Widows Ltd. (Investment Portfolio)
1.145 %
1,940,078 1.145 % 45 M ₹
Aditya Birla Sun Life Amc Ltd. (Investment Management)
1.038 %
1,757,928 1.038 % 41 M ₹
Nippon Life India Asset Management Ltd. (Invt Mgmt)
0.9910 %
1,678,804 0.9910 % 39 M ₹
Kotak Mahindra Asset Management Co. Ltd.
0.6563 %
1,111,796 0.6563 % 26 M ₹
Government of India
0.5680 %
962,205 0.5680 % 22 M ₹
quant Money Managers Ltd.
0.5077 %
860,000 0.5077 % 20 M ₹
SBI Funds Management Ltd.
0.4794 %
812,116 0.4794 % 19 M ₹

Company contact information

GlaxoSmithKline Pharmaceuticals Ltd.

GSK House Dr. Annie Besant Road

400030, Mumbai

+91 22 2495 9595

http://www.gsk-india.com
address GlaxoSmithKline Pharmaceuticals Limited(GLAXO)

Group companies

NameCategory and Sector
Biddle Sawyer Ltd.

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Other Pharmaceuticals

Sales per region

Ratings for GlaxoSmithKline Pharmaceuticals Limited

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
4
Last Close Price
2,065 INR
Average target price
2,141 INR
Spread / Average Target
+3.67%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

1st Jan change Capi.
NOVO NORDISK A/S Stock Novo Nordisk A/S
+24.17% 562B
JOHNSON & JOHNSON Stock Johnson & Johnson
-6.33% 358B
MERCK & CO., INC. Stock Merck & Co., Inc.
+19.90% 322B
ABBVIE INC. Stock AbbVie Inc.
+7.95% 297B
ASTRAZENECA PLC Stock AstraZeneca PLC
+13.45% 219B
NOVARTIS AG Stock Novartis AG
+6.04% 199B
ROCHE HOLDING AG Stock Roche Holding AG
-10.51% 196B
PFIZER, INC. Stock Pfizer, Inc.
-12.26% 149B
AMGEN INC. Stock Amgen Inc.
-6.47% 146B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. GLAXO Stock
  4. GLAXO Stock
  5. Company GlaxoSmithKline Pharmaceuticals Limited